Company Filing History:
4 out of 33 
4 out of 441 
Years Active: 2019-2024
Title: The Innovations of Sho Tsukamoto
Introduction
Sho Tsukamoto is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ectopic ossification and brain tumors. With a total of 4 patents to his name, Tsukamoto's work is recognized for its potential impact on medical treatments.
Latest Patents
One of Tsukamoto's latest patents is a method of treating ectopic ossification or diffuse intrinsic pontine glioma in a subject by administering an anti-ALK2 antibody. This application relates to a pharmaceutical composition designed to treat and prevent conditions in patients with an active mutation in the ALK2 protein. The composition includes an anti-ALK2 antibody that binds to ALK2, cross-links it, and inhibits BMP signal transduction. Another significant patent involves an anti-ALK2 antibody that specifically binds to the ALK2 protein and inhibits BMP signal transduction mediated by ALK2. This patent also outlines a method for producing the antibody and a pharmaceutical composition for treating ectopic ossification, bone dysplasia, anemia, or diffuse intrinsic pontine glioma.
Career Highlights
Throughout his career, Tsukamoto has worked with esteemed institutions such as Saitama Medical University and Daiichi Sankyo Company, Limited. His research and innovations have contributed to advancements in medical science, particularly in the development of targeted therapies.
Collaborations
Some of Tsukamoto's notable coworkers include Takenobu Katagiri and Shinnosuke Tsuji. Their collaborative efforts have further enhanced the research and development of innovative treatments in their field.
Conclusion
Sho Tsukamoto's contributions to the field of pharmaceuticals demonstrate his commitment to advancing medical science through innovation. His patents reflect a dedication to improving treatment options for patients with complex medical conditions.